Back to search

Boston University

A new oncogenic function of the glycolytic enzyme lactate dehydrogenase-A in small cell lung cancer

Abstract

dc:description.abstract

Small Cell Lung Cancer (SCLC) is an epithelial cancer that has, until recent years, been labeled a recalcitrant tumor type. Since its discovery and classification, there has been very little research to understand and treat SCLC. Conventional methods of treatment for SCLC include chemotherapeutics have been used with little long-term success. Following initial treatment, the cancer appears to be fully wiped out, however seemingly without fail the cancer reemerges with acquired drug resistance and the capability to rapidly metastasize, leading to a five-year survival rate of less than 10%. While there have been continuous improvements in the field of cancer therapeutics, combining chemotherapeutics and immunotherapy, there has been no targeted clinical therapy for SCLC. Recent studies have suggested that an acidic tumor microenvironment is highly important for the progression of other cancers. LDHA generates lactate from pyruvate, leading to a more acidic environment, which indicates LDHA may be a viable target for cancer therapeutics. CRISPR-cas9 gene editing and mouse SCLC cell lines were used to study lactate concentration and cell vitality. After analysis of several different SCLC tumors, larger tumors had both a higher metastatic capability and higher concentrations of lactate, indicating that LDHA was more highly active in these tumors. CRISPR-cas9 knockout targeting of LDHA decreased SCLC colony formation and cellular growth in vitro, leading to the conclusion that LDHA may play a vital role in the future as a potential therapeutic target for the treatment of SCLC.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gramyk, Tobin
Advisor dc:contributor.advisor
  • Trinkaus-Randall, Vickery

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/36338

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gramyk, Tobin. A new oncogenic function of the glycolytic enzyme lactate dehydrogenase-A in small cell lung cancer. masters thesis, Boston University, 2019. https://hdl.handle.net/2144/36338